Samantha E. Greenberg, MS, MPH, CGC

Languages spoken: English

Academic Information

Departments: Huntsman Cancer Institute - Midlevel, Internal Medicine - Adjunct Assistant Professor, Population Health Sciences - Adjunct Assistant Professor

Divisions: HCI Providers, Oncology

Academic Office Information

Samantha.Greenberg@hci.utah.edu

(801) 587-9555

Huntsman Cancer Institute Research South

2000 Circle of Hope, Room:
Salt Lake City, UT 84112

Board Certification

  • American Board of Genetic Counseling

Research Interests

  • Cancer Genetics
  • Paraganglioma
  • Genetic Studies of Hereditary Prostate Cancer
  • Health Care Quality, Access, and Evaluation

Education History

Doctoral Training University of Utah
 PHD
Graduate Training University of Michigan
Health Behavior and Health Education 		M.P.H.
Graduate Training University of Michigan
Genetic Counseling 		M.S.
Undergraduate University of Michigan
Neuroscience, Honors 		B.S.

Selected Publications

  1. Greenberg SE, Jacobs MF (2022). Continuing the Evolution of Germline Genetics in Prostate Cancer: Tailoring Testing To Enhance Patient Care. Eur Urol.
  2. Maxwell KN, Cheng HH, Powers J, Gulati R, Ledet EM, Morrison C, Le A, Hausler R, Stopfer J, Hyman S, Kohlmann W, Naumer A, Vagher J, Greenberg SE, Naylor L, Laurino M, Konnick EQ, Shirts BH, AlDubayan SH, Van Allen EM, Nguyen B, Vijai J, Abida W, Carlo MI, Dubard-Gault M, Lee DJ, Maese LD, Mandelker D, Montgomery B, Morris MJ, Nicolosi P, Nussbaum RL, Schwartz LE, Stadler Z, Garber JE, Offit K, Schiffman JD, Nelson PS, Sartor O, Walsh MF, Pritchard CC (2021). Inherited TP53 Variants and Risk of Prostate Cancer. Eur Urol.
  3. Greenberg SE, Holman R, Kohlmann W, Buchmann L, Naumer A (2021). Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50. Clin Endocrinol (Oxf), 95(3), 447-452.
  4. Greenberg SE, Hunt TC, Ambrose JP, Lowrance WT, Dechet CB, ONeil BB, Tward JD (2021). Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion. JCO Precis Oncol, 5.
  5. Boothe E, Greenberg S, Delaney CL, Cohen SA (2020). Genetic counseling service delivery models: A study of genetic counselors' interests, needs, and barriers to implementation. J Genet Couns, 30(1), 283-292.
  6. Khan A, Cohen S, Weir C, Greenberg S (2020). Implementing innovative service delivery models in genetic counseling: a qualitative analysis of facilitators and barriers. J Genet Couns, 30(1), 319-328.
  7. Greenberg SE, Boothe E, Delaney CL, Noss R, Cohen SA (2020). Genetic Counseling Service Delivery Models in the United States: Assessment of changes in use from 2010 to 2017. J Genet Couns, 29(6), 1126-1141.
  8. Greenberg SE, Jacobs MF, Wachtel H, Anson A, Buchmann L, Cohen DL, Bonanni M, Bennett B, Naumer A, Schaefer AM, Kohlmann W, Nathanson KL, Else T, Fishbein L (2020). Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome. Genet Med, 22(12), 2101-2107.
  9. Greenberg S, Slager S, Neil BO, Cooney K, Maughan B, Stopa N, Venne V, Zickmund S, Colonna S (2020). What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing. Prostate, 80(5), 441-450.
  10. Boyle JL, Hahn AW, Kapron AL, Kohlmann W, Greenberg SE, Parnell TJ, Teerlink CC, Maughan BL, Feng BJ, Cannon-Albright L, Agarwal N, Cooney KA (2020). Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer. JCO Precis Oncol, 4.
  11. Miller I, Greenberg S, Yashar BM, Marvin ML (2019). Improving access to cancer genetic services: perspectives of high-risk clients in a community-based setting. J Community Genet, 11(1), 119-123.
  12. Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney C (2019). Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing. Cancer Med, 8(15), 6789-6798.
  13. McCrary HC, Babajanian E, Calquin M, Carpenter P, Casazza G, Naumer A, Greenberg S, Kohlmann W, Cannon R, Monroe MM, Hunt JP, Buchmann L (2019). Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades. JAMA Otolaryngol Head Neck Surg, 145(7), 641-646.
  14. Ponte A, Greenberg S, Greendale K, Senier L (2019). Moving the Needle on Action Around Evidence-Based Screening for Hereditary Conditions: Preparing State Chronic Disease Directors to Advance Precision Public Health. Public Health Rep, 134(3), 228-233.
  15. Greenberg S, Yashar BM, Pearlman M, Duquette D, Milliron K, Marvin M (2018). Evaluating and improving the implementation of a community-based hereditary cancer screening program. J Community Genet, 10(1), 51-60.
  16. Rathi N, Anderson N, Greenberg S, Vagher J, Agarwal N, Hahn AW (2018). DNA Damage Repair (DDR) Mutations and the Utility of High-Risk Genetics Clinics in Metastatic Castration-Refractory Prostate Cancer (mCRPC). World J Oncol, 9(4), 119-122.
  17. Martin C, Leiser CL, ONeil B, Gupta S, Lowrance WT, Kohlmann W, Greenberg S, Pathak P, Smith KR, Hanson HA (2017). Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control Study. J Natl Cancer Inst, 110(5), 527-533.
  18. Gupta S, Greenberg S, Grimmett J, Gaston D, Agarwal N, Lowrance W, Schiffman J, Kohlmann W (2017). Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers. Fam Cancer, 16(4), 545-550.